Cleared Traditional

K070174 - AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS; ROCHE SCRIPTS FOR CT/NG TEST ACCESSORY
(FDA 510(k) Clearance)

Apr 2007
Decision
88d
Days
Class 1
Risk

K070174 is an FDA 510(k) clearance for the AMPLICOR CT/NG TEST FOR CHLAMYDIA TRACHOMATIS; ROCHE SCRIPTS FOR CT/NG TEST ACCESSORY. This device is classified as a Dna Probe, Nucleic Acid Amplification, Chlamydia (Class I - General Controls, product code MKZ).

Submitted by Roche Diagnostics Corporation (Indianpolis, US). The FDA issued a Cleared decision on April 16, 2007, 88 days after receiving the submission on January 18, 2007.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3120.

Submission Details

510(k) Number K070174 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 18, 2007
Decision Date April 16, 2007
Days to Decision 88 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code MKZ — Dna Probe, Nucleic Acid Amplification, Chlamydia
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3120

Similar Devices — MKZ Dna Probe, Nucleic Acid Amplification, Chlamydia

All 18
Aptima? Chlamydia trachomatis Assay
K230451 · Hologic, Inc. · Nov 2023
BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY
K140446 · Becton, Dickinson & CO · May 2014
COBAS 4800 CT / NG TEST
K110923 · Roche Molecular Systems, Inc. · Jan 2012
BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) Q AMPLIFIED DNA ASSAY
K091724 · Becton, Dickinson & CO · Nov 2009
BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY
K090824 · Becton, Dickinson & CO · Jun 2009
BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) Q AMPLIFIED DNA ASSAY
K081824 · Becton, Dickinson & CO · Dec 2008